Form D · Other
MERA PHARMACEUTICALS INC
Boca Raton, FL · CIK 0000837490
Offering snapshot reported Jul 12, 2012 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 45 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 14, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 12, 2012 | Initial | $0 | No comparison | 45 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-181120
Share exchange - no offering amount.
Source: Form D, filed Jul 12, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joyce Markley | Director |
| Charles Gary Spaniak | Director, Executive |
| Fred Villari | Director |
| Lawrence Wolfe | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
2240 Nw 19th Street Suite 911
Boca Raton, FL, 33431
Boca Raton, FL, 33431